Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea: A meta-analysis of randomized controlled trials

International Journal of STD and AIDS

Volumn 23, Issue 2, 2012, Pages 126-132

  Bai, Z G ^a   Bao, X J ^b   Cheng, W D ^a   Yang, K H ^a   Li, Y P ^c  

^a LANZHOU UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c Chinese Cochrane Centre   (China)

Author keywords

Cefixime; Cefotaxime; Ceftriaxone; Gonorrhoea; Meta analysis; Spectinomycin; Treatment

Indexed keywords

CEFIXIME; CEFTRIAXONE; SPECTINOMYCIN;

ARTICLE; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; GONORRHEA; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CEFIXIME; CEFTRIAXONE; GONORRHEA; HUMANS; MIDDLE AGED; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPECTINOMYCIN; TREATMENT OUTCOME;

EID: 84863261940     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009198     Document Type: Article

References (27)

1. Lowndes CM, Fenton KA. Epidemiology of STIs: UK. Medicine 2005;33:1-4
2. Sherrard J. Gonorrhoea. Bact Infect 2005;9:37-38
3. Crabbe F, Vuylsteke B, De Clerck M, Laga M. Cost-effectiveness of management strategies for acute urethritis in the developing world. Trop Med Int Health 2000;5:640-47
4. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-110
5. Ilina EN, Borovskaya AD, Malakhova MM, et al. Direct bacterial profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for identification of pathogenic Neisseria. J Mol Diagn 2009;11:75-86
6. Sherrard J. Gonorrhoea. Bacterial Infections 2010;38:245-48
7. Pearson RL, Ferri FF, Jones RC, Opal SM. Gonorrhea. St Louis: Elsevier, 2004
8. Cole MJ, Chisholm SA, Hoffmann S, et al. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex Transm Infect 2010;86:427-32
9. Bignell C. 2009 European (IUSTI/WHO) Guideline on the Diagnosis and Treatment of Gonorrhoea in Adults. International Journal of STD & AIDS 2009;20:453-57
10. Ison CA, Hughes G. Gonorrhoea themed issue. Sex Transm Infect 2010;86:409-11
11. Mogabgab WJ, Lutz FB. Randomized study of cefotaxime versus ceftriaxone for uncomplicated gonorrhea. South Med J 1994;87:461-64
12. Anonymous author. Cefotaxime vs. ceftriaxone in the treatment of gonorrhea. Am Fam Physician 1994;50:1126
13. McCormack WM, Mogabgab WJ, Jones RB, et al. Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea. Sex Transm Dis 1993;20:269-73
14. Jones RB, Mogabgab WJ, McCormack WM, Wendel GD. Randomized comparison of cefotaxime and ceftriaxone in patients with uncomplicated gonorrhea. Clin Ther 1991;13:550-56
15. Korting HC, Abeck D. One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime. Chemotherapy 1989;35:441-48
16. Ramus RM, Sheffield JS, Mayfield JA, Wendel GD Jr. A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy. Am J Obstet Gynecol 2001;185:629-32
17. Portilla I, Lutz B, Montalvo M, Mogabgab WJ. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections. Sex Transm Dis 1992;19:94-98
18. Plourde PJ, Tyndall M, Agoki E, et al. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection. J Infect Dis 1992;166:919-22
19. Handsfield HH, McCormack WM, Hook EW, et al. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group. N Engl J Med 1991;325:1337-41
20. Cavenee MR, Farris JR, Spalding TR, et al. Treatment of gonorrhea in pregnancy. Obstet Gynecol 1993;81:33-38
21. Panikabutra K, Ariyarit C, Chitwarakorn A, et al. Randomised comparative study of ceftriaxone and spectinomycin in gonorrhoea. Genitourinary Med 1985;61:106-08
22. Collier AC, Judson FN, Murphy VL, et al. Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women. Am J Med 1984;77:68-72
23. Handsfield HH, Murphy VL. Comparative study of ceftriaxone and spectinomycin for treatment of uncomplicated gonorrhoea in men. Lancet 1983;2:67-70
24. Forsyth N. Cefixime or ceftriaxone in gonococcal urethritis? Available from: http://www.bestbets.org/bets/bet.php?id=1186 (last accessed 5 March 2012)
25. Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill 2011;10:pii:19792
26. (CDC). Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 2006;55:1-94
27. Chisholm SA, Mouton JW, Lewis DA, et al. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J Antimicrob Chemother 2010;65:2141-48